Table 3.
Associated factors to incomplete expanded immunization coverage by age 12 month. 2015 Pelotas Birth Cohort
| Incomplete expanded immunisationa | ||||
|---|---|---|---|---|
| Unadjusted | Adjusted | |||
| % | 95% IC | % | 95% IC | |
| Maternal education (years) | 0.001 | 0.024 | ||
| 0 to 4 | 1.05 | 0.90; 1.22 | 1.14 | 0.95; 1.36 |
| 5 to 8 | 0.98 | 0.88; 1.09 | 1.09 | 0.95; 1.25 |
| 9 to 11 | 0.82 | 0.74; 0.92 | 0.92 | 0.82; 1.04 |
| 12 or more | 1 (ref) | – | 1 (ref) | – |
| Family income (quintiles) | < 0.001 | < 0.001 | ||
| Q1 (poorest) | 1 (ref) | – | 1 (ref) | – |
| Q2 | 0.86 | 0.75; 0.98 | 0.88 | 0.77; 1.00 |
| Q3 | 0.78 | 0.68; 0.90 | 0.82 | 0.71; 0.95 |
| Q4 | 0.80 | 0.70; 0.93 | 0.85 | 0.73; 0.99 |
| Q5 (richest) | 1.10 | 0.97; 1.24 | 1.15 | 1.01; 1.34 |
| Maternal age (years) | 0.247 | 0.230 | ||
| < 20 | 1 (ref) | – | 1 (ref) | – |
| 20–35 | 1.06 | 0.94; 1.21 | 1.11 | 0.97; 1.28 |
| > 35 | 1.16 | 0.98; 1.37 | 1.16 | 0.97; 1.39 |
| Maternal skin color | 0.88 | 0.825 | ||
| White | 1 (ref) | – | 1 (ref) | – |
| Brown | 1.03 | 0.91; 1.17 | 1.04 | 0.91; 1.18 |
| Black | 1.02 | 0.90; 1.15 | 1.02 | 0.90; 1.16 |
| Parity | < 0.001 | < 0.001 | ||
| 1 child | 1 (ref) | – | 1 (ref) | – |
| 2 children | 1.21 | 1.09; 1.34 | 1.23 | 1.11; 1.37 |
| 3 children or more | 1.52 | 1.36; 1.68 | 1.52 | 1.35; 1.71 |
| Number of prenatal consultations | < 0.001 | < 0.001 | ||
| 0 to 5 | 1.42 | 1.27; 1.58 | 1.39 | 1.24; 1.56 |
| 6 or more | 1 (ref) | – | 1 (ref) | – |
| Tdapbvaccine during pregnancy | < 0.001 | < 0.001 | ||
| No | 1.22 | 1.12; 1.33 | 1.18 | 1.07; 1.29 |
| Yes | 1 (ref) | – | 1 (ref) | – |
| Breastfedding status at 12 months | < 0.001 | < 0.001 | ||
| No | 1.21 | 1.09; 1.33 | 1.24 | 1.12; 1.37 |
| Yes | 1 (ref) | – | 1 (ref) | – |
| Use of public health care services | < 0.001 | < 0.001 | ||
| No | 1.25 | 1.10; 1.41 | 1.22 | 1.06; 1.39 |
| Yes | 1 (ref) | – | – | |
aIncomplete immunization defined as not have reached the complete scheduled vaccine doses of national immunization program for the first year of life
bTdap: tetanus toxoid, reduced difteria toxoid and acellular pertussis